3 ms·
"Big RCT Fundamentalism" is an interesting term. Reductionist positions are not uncommon. A test of 20 people would very probably not have uncovered the unusua
by ggm 5y ago
"Big RCT Fundamentalism" is an interesting term. Reductionist positions are not uncommon.
A test of 20 people would very probably not have uncovered the unusual clotting problem in AZ, which is 1:100,000 order occurance. Yet, it has shaped public policy.
Tests of the order 1,000 would confirm AZ worked. Tests of the order 10,000 confirmed Pfizer and Moderna worked "better"
The PEG problem in mRNA, like the clotting problem, needs tests of the order 1m to become apparent.
If Ivermectin and HCQ had benefits, they'd be clearer if better RCT at scale were done. The benefit of steroids (for instance) were so clear, they were able to decide the protocols from thousands of tests (from what I read) which is maybe what "big RCT fundamentalism" tells us: These trials of 10 or 20 people, observational, are too strongly distorted by one and two person effects to say what the underlying trend is.
In primary school we were warned away from small sample sizes in basic stats. I'm not seeing anything here to make me think this was wrong. 100 people tell you more than 10 do, and 1000 confirms the accuracy. 1 person variance in 100 is not altering the fundamentals the way 1 person variance in 10 is.
Whats so "fundamentalist" about this?
- shaicoleman 5y ago> Whats so "fundamentalist" about this? For example take this peer-reviewed study for Ivermectin as a prophylaxis which was published back in Nov/2020. https://c19ivermectin.com/carvalloprep.html https://c19ivermectin.com/carvalloprep.html https://medicalpressopenaccess.com/upload/1605709669_1007.pdf https://medicalpressopenaccess.com/upload/1605709669_1007.pd... * 0 out of 788 (0%) in the treatment group got COVID. * 237 out of 408 (58.2%) in the control group got COVID. The treatment group were volunteers who agreed to take it, so it wasn't an RCT. "Big RCT Fundamentalism" discards that study, because it wasn't a big RCT, even though the signal to noise is obviously clear, and it has been replicated study after study, including smaller RCTs (when using a weekly dose of at least 0.2mg/kg). There are no big RCTs that show the same effect, because they can cost millions and there's no incentive for anyone to fund it.
- ggm 5y agoYou're using a very specific complaint about science formalism not about numbers but about recruitment and randomisation. My comment went to numbers, not recruitment. If your problem is outsider science, please be more specific. You could (for instance) cite PLOS one reports on Ivermectin instead of random domains with an axe to grind: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0242184&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+plosone%2FPLoSONE+%28PLOS+ONE+-+New+Articles%29 https://journals.plos.org/plosone/article?id=10.1371/journal... https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0247163 https://journals.plos.org/plosone/article?id=10.1371/journal... https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0242184 https://journals.plos.org/plosone/article?id=10.1371/journal...
- shaicoleman 5y agoYou can find the same study in ResearchGate. The domain name doesn't change the content. https://www.researchgate.net/publication/346034534_Study_of_the_Efficacy_and_Safety_of_Topical_Ivermectin_Iota-_Carrageenan_in_the_Prophylaxis_against_COVID-19_in_Health_Personnel https://www.researchgate.net/publication/346034534_Study_of_... The ivmmeta website is a collection of public information, you can always refer to the original study/journal if you don't find it trustworthy. It's not a lack of data. Ivermectin already has many times more data (including RCTs) compared to other WHO approved treatments (Ivermectin vs. Remdesivir, Ivermectin for COVID-19 vs Ivermectin for Scabies). https://ivmmeta.com/#table_whoapproval https://ivmmeta.com/#table_whoapproval